老年肺部侵袭性真菌感染患者伏立康唑谷浓度与肝功能损伤的关系

程林; 翁邦碧; 向荣凤; 孙凤军

doi:10.16016/j.1000-5404.202005071

您当前的位置：

首页 >

文章列表页 >

老年肺部侵袭性真菌感染患者伏立康唑谷浓度与肝功能损伤的关系

临床医学 | 更新时间：2026-01-09

- 老年肺部侵袭性真菌感染患者伏立康唑谷浓度与肝功能损伤的关系
- Relationship between voriconazole trough concentration and liver injury in elderly patients with lung invasive aspergillosis
- 第三军医大学学报 2020年42卷第19期页码：1944-1949
- 作者机构：
- 作者简介：
- 基金信息：
  
  陆军军医大学第一附属医院医务人员军事医学创新能力提升计划(SWH2019QNLC-05)
- DOI：10.16016/j.1000-5404.202005071
  中图分类号：
- 收稿：2020-05-10，
  
  纸质出版：2020-10-15
- 稿件说明：
移动端阅览
程林, 翁邦碧, 向荣凤, 等. 老年肺部侵袭性真菌感染患者伏立康唑谷浓度与肝功能损伤的关系[J]. 第三军医大学学报, 2020,42(19):1944-1949.

Lin CHENG, Bangbi WENG, Rongfeng XIANG, et al. Relationship between voriconazole trough concentration and liver injury in elderly patients with lung invasive aspergillosis[J]. Journal of Third Military Medical University, 2020, 42(19): 1944-1949.
程林, 翁邦碧, 向荣凤, 等. 老年肺部侵袭性真菌感染患者伏立康唑谷浓度与肝功能损伤的关系[J]. 第三军医大学学报, 2020,42(19):1944-1949. DOI： 10.16016/j.1000-5404.202005071.

Lin CHENG, Bangbi WENG, Rongfeng XIANG, et al. Relationship between voriconazole trough concentration and liver injury in elderly patients with lung invasive aspergillosis[J]. Journal of Third Military Medical University, 2020, 42(19): 1944-1949. DOI： 10.16016/j.1000-5404.202005071.

摘要

Abstract

Objective

To investigate the relationship between voriconazole trough concentration and liver injury in elderly patients with lung invasive aspergillosis.

Methods

The clinical data of patients receiving voriconazole therapeutic drug monitoring matched with the inclusion criteria

who admitted to our hospital from 1 January

2018 to 30 June

2019 were retrospectively analyzed. Patients were divided into elderly group (≥60 years) and adult group (≥18~ < 60 years) according to age. The route of administration

daily voriconazole dose

voriconazole trough concentration

and liver injury of patients were compared between the two groups.

Results

A total of 179 patients with lung invasive aspergillosis were included in

with 329 voriconazole trough concentration. There were 87 patients in elderly group

with 131 voriconazole trough concentration. There were 92 patients in elderly group

with 198 voriconaz

ole trough concentration. Most patients in the elderly group received an intravenous drip

which was higher than that in adult group (

0.01). The voriconazole dosing was similar in the two cohorts (

0.05). The voriconazole trough concentration in elderly group was 3.86 (2.02

6.00) μg/mL

which was higher than 2.6 (1.5

4.0)μg/mL in adult group (

0.01). The proportion of voriconazole trough concentrations higher than 5 μg/mL in the elderly group was higher than that in the adult group (

0.01). The incidence rate of alanine aminotransferase (ALT) increasing in elderly group was lower than that in the adult group (

0.01). The incidence rate of albumin decreasing in elderly group was higher than that in the adult group (

0.01). The incidence of increased alkaline phosphatase (ALP)

ALT

and gamma-glutamyl transpeptidase (GGT) concentrations and decreased albumin level was higher in the elderly group than that in the adult group when the voriconazole trough concentration was higher than 5 μg/mL (

0.05). There were no correlations of voriconazole trough concentration with ALP

ALT

aspartate aminotransferase (AST)

GGT

total bilirubin

and albumin in elderly group (

=0.018

0.154

0.166

-0.171

-0.138

-0.118

0.05). There were positive correlation of voriconazole trough concentration with AST and total bilirubin in adult group (

=0.267

0.618

0.01). There was negative correlation between voriconazole trough concentration and albumin in adult group (

=-0.214

0.05).

Conclusion

The voriconazole trough concentration in elderly patients was higher than that in adult patients; the elderly patients have the high incidence of liver injury when the voriconazole trough concentration was higher than 5 μg/mL; there were no correlations of voriconazole trough concentration and liver function indexes in elderly patients.

关键词

Keywords

references

JIANG M YANG G FANG L Factors associated with healthcare utilization among community-dwelling elderly in Shanghai, China PLoS One 2018 13 12 e0207646 10.1371/journal.pone.0207646 JIANG M, YANG G, FANG L, et al. Factors associated with healthcare utilization among community-dwelling elderly in Shanghai, China[J]. PLoS One, 2018, 13(12): e0207646. DOI:10.1371/journal.pone.0207646.

LIANG S Y Sepsis and other infectious disease emergencies in the elderly Emerg Med Clin North Am 2016 34 3 501 522 10.1016/j.emc.2016.04.005 LIANG S Y. Sepsis and other infectious disease emergencies in the elderly[J]. Emerg Med Clin North Am, 2016, 34(3): 501-522. DOI:10.1016/j.emc.2016.04.005.

MATTHAIOU D K DIMOPOULOS G TACCONE F S Elderly versus nonelderly patients with invasive aspergillosis in the ICU: a comparison and risk factor analysis for mortality from the AspICU cohort Med Mycol 2018 56 6 668 678 10.1093/mmy/myx117 MATTHAIOU D K, DIMOPOULOS G, TACCONE F S, et al. Elderly versus nonelderly patients with invasive aspergillosis in the ICU: a comparison and risk factor analysis for mortality from the AspICU cohort[J]. Med Mycol, 2018, 56(6): 668-678. DOI:10.1093/mmy/myx117.

OREN I PAUL M Up to date epidemiology, diagnosis and management of invasive fungal infections Clin Microbiol Infect 2014 20 Suppl 6 1 4 10.1111/1469-0691.12642 OREN I, PAUL M. Up to date epidemiology, diagnosis and management of invasive fungal infections[J]. Clin Microbiol Infect, 2014, 20(Suppl 6): 1-4. DOI:10.1111/1469-0691.12642.

ULLMANN A J AGUADO J M ARIKAN-AKDAGLI S Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline Clin Microbiol Infect 2018 24 (Suppl 1 e1 e38 10.1016/j.cmi.2018.01.002 ULLMANN A J, AGUADO J M, ARIKAN-AKDAGLI S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline[J]. Clin Microbiol Infect, 2018, 24(Suppl 1): e1-e38. DOI:10.1016/j.cmi.2018.01.002.

CHENG L XIANG R F LIU F Therapeutic drug monitoring and safety of voriconazole in elderly patients Int Immunopharmacol 2020 78 106078 10.1016/j.intimp.2019.106078 CHENG L, XIANG R F, LIU F, et al. Therapeutic drug monitoring and safety of voriconazole in elderly patients[J]. Int Immunopharmacol, 2020, 78: 106078. DOI:10.1016/j.intimp.2019.106078.

CHEN K ZHANG X L KE X Y Individualized medication of voriconazole: a practice guideline of the Division of therapeutic drug monitoring, Chinese pharmacological society Ther Drug Monit 2018 40 6 663 674 10.1097/FTD.0000000000000561 CHEN K, ZHANG X L, KE X Y, et al. Individualized medication of voriconazole: a practice guideline of the Division of therapeutic drug monitoring, Chinese pharmacological society[J]. Ther Drug Monit, 2018, 40(6): 663-674. DOI:10.1097/FTD.0000000000000561.

王陶陶陈思颖尤海生侵袭性真菌感染患者伏立康唑肝毒性的研究中国药学杂志 2018 53 4 290 294 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyxzz201804009 王陶陶, 陈思颖, 尤海生, 等.侵袭性真菌感染患者伏立康唑肝毒性的研究[J].中国药学杂志, 2018, 53(4): 290-294.

WANG T T CHEN S Y YOU H S Hepatotoxicity study of voriconazole therapy in patients with invasive fungal infections Chin Pharm J 2018 53 4 290 294 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyxzz201804009 WANG T T, CHEN S Y, YOU H S, et al. Hepatotoxicity study of voriconazole therapy in patients with invasive fungal infections[J]. Chin Pharm J, 2018, 53(4): 290-294.

HASHEMIZADEH Z BADIEE P MALEKHOSEINI S A Observational study of associations between voriconazole therapeutic drug monitoring, toxicity, and outcome in liver transplant patients Antimicrob Agents Chemother 2017 61 12 e01211 e01217 10.1128/AAC.01211-17 HASHEMIZADEH Z, BADIEE P, MALEKHOSEINI S A, et al. Observational study of associations between voriconazole therapeutic drug monitoring, toxicity, and outcome in liver transplant patients[J]. Antimicrob Agents Chemother, 2017, 61(12): e01211-e01217. DOI:10.1128/AAC.01211-17.

向荣凤尚圣兰熊丽蓉液相色谱-串联质谱法测定人血浆中伏立康唑和伏立康唑氮氧化物浓度及其临床应用第三军医大学学报 2019 41 15 1478 1484 http://aammt.tmmu.edu.cn/Upload/rhtml/201902067.htm 向荣凤, 尚圣兰, 熊丽蓉, 等.液相色谱-串联质谱法测定人血浆中伏立康唑和伏立康唑氮氧化物浓度及其临床应用[J].第三军医大学学报, 2019, 41(15): 1478-1484.

XIANG R F SHANG S L XIONG L R Determination of voriconazole and its N-oxide in human plasma by LC-MS/MS and its clinical application J Third Mil Med Univ 2019 41 15 1478 1484 http://aammt.tmmu.edu.cn/Upload/rhtml/201902067.htm XIANG R F, SHANG S L, XIONG L R, et al. Determination of voriconazole and its N-oxide in human plasma by LC-MS/MS and its clinical application[J]. J Third Mil Med Univ, 2019, 41(15): 1478-1484.

王思杨荣礼陈梦楠老年2型糖尿病合并真菌感染病人的临床特征及预后分析实用老年医学 2010 33 6 561 563 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=sylnyx201906012 王思, 杨荣礼, 陈梦楠, 等.老年2型糖尿病合并真菌感染病人的临床特征及预后分析[J].实用老年医学, 2010, 33(6):561-563.

WANG S YANG R L CHEN M N Analysis of clinical characteristics and prognostic factors in the elderly patients with type 2 diabetes mellitus complicated with fungal infection Practical Geriatrics 2019 33 6 561 563 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=sylnyx201906012 WANG S, YANG R L, CHEN M N, et al. Analysis of clinical characteristics and prognostic factors in the elderly patients with type 2 diabetes mellitus complicated with fungal infection[J]. Practical Geriatrics, 2019, 33(6): 561-563.

王玮琴金晓燕段玉香慢性阻塞性肺疾病急性加重期患者医院真菌感染危险因素分析中华医院感染学杂志 2019 29 10 1483 1486 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyygrxzz201910010 王玮琴, 金晓燕, 段玉香, 等.慢性阻塞性肺疾病急性加重期患者医院真菌感染危险因素分析[J].中华医院感染学杂志, 2019, 29(10):1483-1486.

WANG W Q JIN X Y DUAN Y X Risk factors for fungal infection in patients with acute exacerbation of chronic obstructive pulmonary disease Chinese Journal of Nosocomiology 2019 29 10 1483 1486 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyygrxzz201910010 WANG W Q, JIN X Y, DUAN Y X, et al. Risk factors for fungal infection in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Chinese Journal of Nosocomiology, 2019, 29(10):1483-1486.

LIN X B LI Z W YAN M Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients Br J Clin Pharmacol 2018 84 7 1587 1597 10.1111/bcp.13595 LIN X B, LI Z W, YAN M, et al. Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients[J]. Br J Clin Pharmacol, 2018, 84(7): 1587-1597. DOI:10.1111/bcp.13595.

XU R N GU E M LIU T H The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro Infect Drug Resist 2018 11 2129 2135 10.2147/IDR.S179078 XU R N, GU E M, LIU T H, et al. The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro[J]. Infect Drug Resist, 2018, 11: 2129-2135. DOI:10.2147/IDR.S179078.

SCHMUCKER D L Age-related changes in liver structure and function: Implications for disease? Exp Gerontol 2005 40 8/9 650 659 10.1016/j.exger.2005.06.009 SCHMUCKER D L. Age-related changes in liver structure and function: Implications for disease?[J]. Exp Gerontol, 2005, 40(8/9): 650-659. DOI:10.1016/j.exger.2005.06.009.

WYNNE H A COPE L H MUTCH E The effect of age upon liver volume and apparent liver blood flow in healthy man Hepatology 1989 9 2 297 301 10.1002/hep.1840090222 WYNNE H A, COPE L H, MUTCH E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man[J]. Hepatology, 1989, 9(2): 297-301. DOI:10.1002/hep.1840090222.

DONG M H BETTENCOURT R BARRETT-CONNOR E Alanine aminotransferase decreases with age: the rancho bernardo study PLoS One 2010 5 12 e14254 10.1371/journal.pone.0014254 DONG M H, BETTENCOURT R, BARRETT-CONNOR E, et al. Alanine aminotransferase decreases with age: the rancho bernardo study[J]. PLoS One, 2010, 5(12): e14254. DOI:10.1371/journal.pone.0014254.

汤雯姜春燕孙颖口服伏立康唑治疗的侵袭性肺部真菌感染高龄患者短期预后及影响因素分析药物不良反应杂志 2020 22 1 12 19 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=ywblfyzz202001004 汤雯, 姜春燕, 孙颖.口服伏立康唑治疗的侵袭性肺部真菌感染高龄患者短期预后及影响因素分析[J].药物不良反应杂志, 2020, 22(1):12-19.

TANG W JIANG C Y SUN Y Analysis on short‑term prognosis and influencing factors of oral voriconazole in elderly patients with invasive pulmonary fungal infection ADRJ 2020 22 1 12 19 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=ywblfyzz202001004 TANG W, JIANG C Y, SUN Y, et al. Analysis on short‑term prognosis and influencing factors of oral voriconazole in elderly patients with invasive pulmonary fungal infection[J]. ADRJ, 2020, 22(1):12-19.

VANSTRAELEN K WAUTERS J DE LOOR H Protein-binding characteristics of voriconazole determined by high-throughput equilibrium Dialysis J Pharm Sci 2014 103 8 2565 2570 10.1002/jps.24064 VANSTRAELEN K, WAUTERS J, DE LOOR H, et al. Protein-binding characteristics of voriconazole determined by high-throughput equilibrium Dialysis[J]. J Pharm Sci, 2014, 103(8): 2565-2570. DOI:10.1002/jps.24064.

VANSTRAELEN K WAUTERS J VERCAMMEN I Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients Antimicrob Agents Chemother 2014 58 11 6782 6789 10.1128/AAC.03641-14 VANSTRAELEN K, WAUTERS J, VERCAMMEN I, et al. Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients[J]. Antimicrob Agents Chemother, 2014, 58(11): 6782-6789. DOI:10.1128/AAC.03641-14.

VERINGA A TER AVEST M SPAN L F Voriconazole metabolism is influenced by severe inflammation: a prospective study J Antimicrob Chemother 2017 72 1 261 267 10.1093/jac/dkw349 VERINGA A, TER AVEST M, SPAN L F, et al. Voriconazole metabolism is influenced by severe inflammation: a prospective study[J]. J Antimicrob Chemother, 2017, 72(1): 261-267. DOI:10.1093/jac/dkw349.

GAUTIER-VEYRET E TRUFFOT A BAILLY S Inflammation is a potential risk factor of voriconazole overdose in hematological patients Fundam Clin Pharmacol 2019 33 2 232 238 10.1111/fcp.12422 GAUTIER-VEYRET E, TRUFFOT A, BAILLY S, et al. Inflammation is a potential risk factor of voriconazole overdose in hematological patients[J]. Fundam Clin Pharmacol, 2019, 33(2): 232-238. DOI:10.1111/fcp.12422.

王晓晨王思箭刘林夕伏立康唑个体化给药研究进展中国抗生素杂志 2020 45 1 16 25 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgksszz202001003 王晓晨, 王思箭, 刘林夕, 等.伏立康唑个体化给药研究进展[J].中国抗生素杂志, 2020, 45(1):16-25. WANG X C, WANG S J, LIU L X, et al. Advances in individualized administration of voriconazole[J]. Chin J Antibio, 2020, 45(1):16-25. (收稿:2020-05-10;修回:2020-06-05)

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

伏立康唑所致低血钾和低血钠及其与伏立康唑谷浓度的关系研究

良性前列腺增生老年患者术前沟通问题提示列表构建及其应用效果的随机对照研究

谷氨酰胺对老年髋部骨折患者术后早期营养支持耐受性及炎症反应的影响

复合氯胺酮麻醉对老年抑郁症患者电休克治疗的认知保护作用：一项随机对照研究